Neogen Corp. Announces Director Changes and Compensation Updates
Ticker: NEOG · Form: 8-K · Filed: Apr 5, 2024 · CIK: 711377
| Field | Detail |
|---|---|
| Company | Neogen Corp (NEOG) |
| Form Type | 8-K |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.16, $350,000, $335,000, $200,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-compensation, board-changes
Related Tickers: NEOG
TL;DR
NEOG board shakeup: Director out, new director in, comp changes filed.
AI Summary
On April 1, 2024, Neogen Corporation (NEOG) filed an 8-K report detailing the departure of Director Dr. Steven L. Klink and the election of new Director Dr. David E. MacLean. The filing also announced changes in officer compensation arrangements.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- Neogen Corporation (company) — Registrant
- Dr. Steven L. Klink (person) — Departing Director
- Dr. David E. MacLean (person) — Newly Elected Director
- April 01, 2024 (date) — Date of earliest event reported
FAQ
Who is the departing director and when did their departure become effective?
Dr. Steven L. Klink departed as a director, with the earliest event reported on April 01, 2024.
Who is the newly elected director?
Dr. David E. MacLean was elected as a director.
What is Neogen Corporation's state of incorporation?
Neogen Corporation is incorporated in Michigan.
What is Neogen Corporation's fiscal year end?
Neogen Corporation's fiscal year ends on May 31.
What are the main items reported in this 8-K filing?
The filing reports the departure of a director, the election of a new director, and changes to compensatory arrangements of certain officers.
Filing Stats: 741 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-04-05 10:55:29
Key Financial Figures
- $0.16 — nge on which registered Common Stock, $0.16 par value per share NEOG Nasdaq Glo
- $350,000 — ll be entitled to a base cash salary of $350,000 and will be eligible for an annual targ
- $335,000 — s and a one-time equity award valued at $335,000, comprised equally of options and restr
- $200,000 — pensation target equity award valued at $200,000, which is comprised equally of options
Filing Documents
- neog-20240401.htm (8-K) — 40KB
- 0000950170-24-042096.txt ( ) — 151KB
- neog-20240401.xsd (EX-101.SCH) — 24KB
- neog-20240401_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGEN CORPORATION Date: April 5, 2024 By: /s/ Amy M. Rocklin Name: Amy M. Rocklin Title: Chief Legal & Compliance Officer, Corporate Secretary